Showing results 10 to 10 of 10
< previous
| Title | Author(s) | Issue Date | Views | |
|---|---|---|---|---|
Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of HBeAg-positive chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial Journal:The Lancet Gastroenterology & Hepatology | 2016 | 27 |